Fig. 4.
Fig. 4. AP-1, SP-1, and Egr-1 binding in nuclear extracts from HA-1 cells incubated with 100 μM ZnCl2 or 10 μM MPs for 24 hours. / Each panel represents an electrophoretic mobility shift gel from 3 separate experiments. (A) AP-1 binding. Lane F, free probe; lane C; untreated control; lane ZC, cells incubated with ZnCl2; lane ZP, cells incubated with ZnPP; lane SP, cells incubated with SnPP; lane CP, cells incubated with CrPP; lane ZC+AP-1, ZnCl2treated cells incubated with a 100-fold excess of cold AP-1 probe to demonstrate specificity of binding. (B) SP-1 binding. Lane F, free probe; lane C, untreated control; lane ZC, cells incubated with ZnCl2; lane ZP, cells incubated with ZnPP; lane CP, cells incubated with CrPP; lane SP, cells incubated with SnPP; lane ZC+SP-1, ZnCl2 treated cells incubated with a 100-fold excess of cold SP-1 probe to demonstrate specificity of binding. (C) Egr-1 binding. Lane F, free probe; lane C, untreated control; lane ZP, cells incubated with ZnPP; lane ZC, cells incubated with ZnCl2; lane CP, cells incubated with CrPP; lane SP, cells incubated with SnPP; lane ZP+Egr-1, ZnPP-treated cells incubated with a 100-fold excess of cold Egr-1 probe to demonstrate specificity of binding. In each gel, cold competition was performed with the compound leading to the highest nuclear protein binding.

AP-1, SP-1, and Egr-1 binding in nuclear extracts from HA-1 cells incubated with 100 μM ZnCl2 or 10 μM MPs for 24 hours.

Each panel represents an electrophoretic mobility shift gel from 3 separate experiments. (A) AP-1 binding. Lane F, free probe; lane C; untreated control; lane ZC, cells incubated with ZnCl2; lane ZP, cells incubated with ZnPP; lane SP, cells incubated with SnPP; lane CP, cells incubated with CrPP; lane ZC+AP-1, ZnCl2treated cells incubated with a 100-fold excess of cold AP-1 probe to demonstrate specificity of binding. (B) SP-1 binding. Lane F, free probe; lane C, untreated control; lane ZC, cells incubated with ZnCl2; lane ZP, cells incubated with ZnPP; lane CP, cells incubated with CrPP; lane SP, cells incubated with SnPP; lane ZC+SP-1, ZnCl2 treated cells incubated with a 100-fold excess of cold SP-1 probe to demonstrate specificity of binding. (C) Egr-1 binding. Lane F, free probe; lane C, untreated control; lane ZP, cells incubated with ZnPP; lane ZC, cells incubated with ZnCl2; lane CP, cells incubated with CrPP; lane SP, cells incubated with SnPP; lane ZP+Egr-1, ZnPP-treated cells incubated with a 100-fold excess of cold Egr-1 probe to demonstrate specificity of binding. In each gel, cold competition was performed with the compound leading to the highest nuclear protein binding.

Close Modal

or Create an Account

Close Modal
Close Modal